| ₹ crore | Q2 FY27 | Year before | Change |
|---|---|---|---|
| Revenue | 89.3 | — | — |
| EBITDA | 26.4 | — | — |
| EBITDA margin | 29.5% | — | — |
| Profit before tax | 18.6 | — | — |
| Net profit | 13.5 | — | — |
| EPS | ₹5.48 | — | — |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 |
|---|
| 1,531 | — | |
| 40.8 | 27.4 | |
| 76.9 | 76.9 | |
| 1,567 | — | |
| 277 | 219 | |
| 80.2 | 60.8 | |
| 29.0% | 27.8% | |
| 50.4 | 39.4 | |
| 47.3 | 39.3 | |
| 17.1% | 18.0% | |
| ₹19.18 | ₹15.95 | |
| — | 53.7 | |
| — | −88.1 | |
| −34.4 | −34.4 | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|
| Market Capitalization | — | 1,530.7 | |
| - Cash, Equiv & ST Investments | 27.4 | 40.8 | |
| + Total Debt | 76.9 | 76.9 | |
| Enterprise Value | — | 1,566.8 | |
| Revenue | 218.6 | 276.8 | |
| EBITDA | 60.8 | 80.2 | |
| Margin % | 27.81 | 28.96 | |
| EBIT | 39.4 | 50.4 | |
| Net Income | 39.3 | 47.3 | |
| Margin % | 17.99 | 17.09 | |
| EPS, Adj (current shares) | 15.95 | 19.18 | |
| Cash from Operations | 53.7 | — | |
| Capital Expenditures | -88.1 | — | |
| Free Cash Flow | -34.4 | -34.4 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
Paushak (NSE: PAUSHAKLTD) had a market capitalisation of ₹1,450 crore at the 30 October 2026 close (₹588.20 a share), a PE ratio of 30.7 on the last four quarters' profit and a price-to-book ratio of 2.81. In FY26 its consolidated net profit was ₹39.3 crore on revenue of ₹219 crore; in Q2 FY27 (July–September 2026) it was ₹13.5 crore. Its debt-to-equity ratio was 0.13 on 30 September 2026. Promoters held 67.28% of the shares on 30 September 2026.
Paushak's PE ratio is 30.7 at the 30 October 2026 close (₹588.20 a share): a market capitalisation of ₹1,450 crore divided by consolidated net profit of ₹47.3 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit (₹39.3 crore) it is 36.9.
Paushak's price-to-book (PB) ratio is 2.81 at the 30 October 2026 close: a market capitalisation of ₹1,450 crore divided by shareholders' equity (book value) of ₹517 crore on 30 September 2026. That is a book value of ₹209.51 per share against a share price of ₹588.20.
Paushak's net worth — shareholders' equity in its consolidated balance sheet — was ₹517 crore on 30 September 2026. Its market value is a different figure: a market capitalisation of ₹1,450 crore at the 30 October 2026 close.
Paushak's market capitalisation was ₹1,450 crore at the 30 October 2026 close: 2.47 crore shares at ₹588.20 each.
Paushak's debt-to-equity ratio was 0.13 on 30 September 2026: borrowings of ₹67.5 crore against total equity of ₹517 crore.
In 2026, Paushak has declared one dividend: ₹2.50 with record date 23 July 2026.
No. Paushak had borrowings of ₹67.5 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.13. Its cash and current investments were ₹41.7 crore, so its net debt was ₹25.8 crore.
Paushak's book value per share was ₹209.51 on 30 September 2026: shareholders' equity of ₹517 crore divided by the 2.47 crore shares in issue. The share price at the 30 October 2026 close was ₹588.20.
On 30 September 2026, Paushak's shares were held by promoters 67.28%, foreign portfolio investors (FII/FPI) 0.11%, domestic institutions (DII) 0.27% and retail and other non-institutional investors 32.34%.
Paushak's basic earnings per share (EPS) were ₹15.95 in FY26.
Promoters held 67.28% of Paushak on 30 September 2026, unchanged from the previous quarter, according to the shareholding pattern filed with NSE.
Paushak's latest results are for Q2 FY27 (July–September 2026), filed on 16 October 2026: consolidated net profit ₹13.5 crore; revenue from operations ₹89.3 crore.
In FY26, Paushak generated ₹53.7 crore of cash from operations and spent ₹88.1 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹34.4 crore.
In FY26 (April 2025–March 2026), Paushak's consolidated net profit was ₹39.3 crore, on revenue from operations of ₹219 crore.
Paushak has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
On FY26 consolidated figures, against Thirumalai Chemicals and Deepak Nitrite: Paushak's operating margin of 18.0% is the highest of the three (Thirumalai Chemicals −7.1%, Deepak Nitrite 9.6%; peer average 1.2%).
In FY26, Paushak earned net profit of ₹39.3 crore on revenue of ₹219 crore, against ₹168 crore on ₹1,736 crore for Thirumalai Chemicals. Paushak's operating margin was 18.0% (Thirumalai Chemicals −7.1%). At the 30 October 2026 close, Paushak's market capitalisation was ₹1,450 crore against ₹1,379 crore for Thirumalai Chemicals.
From Paushak's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.